Margaret Keenan, the first person outside the trial to receive Pfizer’s coronavirus vaccine, received her second dose on Tuesday, making her the first patient to be fully vaccinated against the coronavirus.
Sky News reports that Keenan received her second dose at Coventry’s University Hospital, three weeks after her first dose was given on December 8.
Receiving her first dose of the vaccine earlier in December, Keenan told reporters it was a “privilege” and “the best early birthday present I could wish for.”
“We were delighted to welcome Margaret Keenan back to Coventry’s University Hospital today to receive the second dose of vaccine safely, after she became the first person in the world to receive the Pfizer COVID-19 after its clinical approval,” he said. Andy Hardy said. CEO of University Coventry.
“It’s important that everyone comes forward to get a jolt when invited to do so, and like other hospitals and GPs across the country, we will follow the latest advice and evidence from experts to invite people to be vaccinated at that time. to become they need it. ‘
We will get through this pandemic together. Https://t.co/jDZq6c0Ths
– Matt Hancock (@MattHancock) 29 December 2020
The news agency reports that more than 616,000 people in the UK have taken their first doses of coronavirus vaccine, although British Prime Minister Boris Johnson said last week that nearly 800,000 people had received a vaccine dose.
The UK has so far only approved the vaccination of Pfizer, although reports have surfaced that the vaccine candidate from AstraZeneca and the University of Oxford will be approved this week.
Coronavirus cases in the UK are soaring with a record number of cases reported on Tuesday.
Aside from increasing cases, the UK is also struggling with a new strain of the coronavirus that has been detected.
The virus variant is more contagious, according to scientists, although it does not appear to cause severe cases of the coronavirus. Health experts in the US and UK have said that the current vaccines released as well as AstraZeneca are likely to be effective against this new strain.
The European Union launched its vaccination campaign on Sunday to encourage citizens to receive the vaccine. The EU aims to immunize all its adults by 2021.